AK

Ashok Kumar Srivastava

Director DIN 03319605
DIN 03319605 First appointment Dec 2010
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Ashok Kumar Srivastava

Data last updated:

Ashok Kumar Srivastava was a Director at Alcor Global Impex Private Limited (from 2016) and Director at Alcor Medipharma Private Limited (from 2010).

DIN 03319605
First Appointment 06 Dec 2010
Oldest Company Age 15 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alcor Global Impex Private Limited U51900UP2016PTC083878
Director07 Jun 20162016Strike Off
Alcor Medipharma Private Limited U51909UP2010PTC042738
Director06 Dec 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Alcor Global Impex Private Limited
Alcor Medipharma Private Limited
Premium access

Shareholding and investment profile for Ashok Kumar Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashok Kumar Srivastava

Ashok Kumar Srivastava was first appointed on 06 Dec 2010 as Director at Alcor Medipharma Private Limited. The most recent appointment on record is 07 Jun 2016 at Alcor Global Impex Private Limited.

Ashok Kumar Srivastava held 2 earlier board appointments: Alcor Global Impex Private Limited (Director, from 07 Jun 2016); Alcor Medipharma Private Limited (Director, from 06 Dec 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available